Pharmacotherapy Choice Is Associated with 2-Year Mortality for Patients with Heart Failure and Reduced Ejection Fraction.

about

Pharmacotherapy Choice Is Associated with 2-Year Mortality for Patients with Heart Failure and Reduced Ejection Fraction.

Item

http://www.wikidata.org/entity/Q47614022

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Pharmacotherapy Choice Is Asso ...... and Reduced Ejection Fraction.

@en

Pharmacotherapy Choice Is Asso ...... and Reduced Ejection Fraction.

@nl

type

Item

label

Pharmacotherapy Choice Is Asso ...... and Reduced Ejection Fraction.

@en

Pharmacotherapy Choice Is Asso ...... and Reduced Ejection Fraction.

@nl

prefLabel

Pharmacotherapy Choice Is Asso ...... and Reduced Ejection Fraction.

@en

Pharmacotherapy Choice Is Asso ...... and Reduced Ejection Fraction.

@nl

P1476

Pharmacotherapy Choice Is Asso ...... and Reduced Ejection Fraction.

@en

P2093

Adrianne Waldman Casebeer

http://www.w3.org/2001/XMLSchema#string

Chun-Lan Chang

http://www.w3.org/2001/XMLSchema#string

Dana A Drzayich Antol

http://www.w3.org/2001/XMLSchema#string

Nancy M Albert

http://www.w3.org/2001/XMLSchema#string

Richard W DeClue

http://www.w3.org/2001/XMLSchema#string

Stephen Stemkowski

http://www.w3.org/2001/XMLSchema#string

Yong Li

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

Recent advances in treatment of heart failure

Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysis

Angiotensin-neprilysin inhibition versus enalapril in heart failure

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

P2888

s12325-017-0618-4

P304

2345-2359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12325-017-0618-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29019079

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy